ABSTRACT: Cells microencapsulated in biocompatible semi-permeable polymeric membranes are effective as cell delivery systems while protecting the host against immune responses. In this study, cell encapsulation membranes were prepared based on carrageenan and alginate, two natural cationic polymers. Different formulations/conditions were explored to optimize the microcapsules which were characterized with respect to their morphology, mechanical stability, and cytotoxicity. Spherical-shaped microcapsules were obtained from all the polymeric systems. The iota-carrageenan/sodium alginate microcapsules exhibited the best stability and permeability, and therefore, these were selected for the cell encapsulation. These capsules provided an environment that supported cell proliferation and have the potential for tissue engineering as well as other cell-based therapy applications.
INTRODUCTION
A n effective method of immunoprotecting cells and proteins for implantation into unmatched recipients, as well as delivery via
MATERIALS AND METHODS

Materials
Iota-carrageenan (22045), kappa-carrageenan (22048), sodium alginate (71238), b-glycerophosphate disodium salt (b-GP/G9891), phosphate buffer saline (PBS-P4417), sodium citrate (S1804), and DAPI (4 0 6-diamidino-2-phenylindole/D9564) were purchased from Sigma (Portugal). Low molecular weight (Mw) chitosan powder was obtained from Aldrich/448869 (Portugal). Calcein-AM (acetoxymethyl ester of calcein) was purchased from Invitrogen/C3099 (Portugal).
Adjustment of the pH of the Chitosan Solutions with b-GP
A solution containing 0.0266 g/mL of b-GP was slowly added to a chitosan solution (0.30% in 0.017 M HCl) until physiological pH 7 was obtained. At this point, precipitation occurs. A curve of the variation of the pH in chitosan solution as a function of b-GP concentration was developed to determine the amount of b-GP to be added to reach the desired pH.
Microcapsules Based on Iota-and Kappa-Carrageenan
Capsules were obtained using chitosan solutions at two different pHs, 5.0 and 6.0, adjusted with b-GP. The microcapsules were obtained by adding 1 mL of an 1.5% aqueous solution of iota (or kappa)-carrageenan dropwise through a 0.3 mm needle (BD-Microfine U-100 insulin, Portugal, using an AL-1000, Aladdin Programmable Syringe Pump) into 20 mL of an 0.15% chitosan in a solution at 0.0085 M HCl. The capsules were allowed to harden for 45 min at 378C in a water bath, washed with 0.9% NaCl and immersed in a 0.05% iota-carrageenan solution for 5 min in order to link the remaining residues of chitosan. The capsules were then rinsed twice with PBS and stored at 48C in the same buffer.
Sodium Alginate/Iota-carrageenan Microcapsules
Aqueous alginate/iota-carrageenan mixtures composed of a 1.5% aqueous solution of each polymer, at two different ratios, 50/50 and 30/70 (v/v), were prepared as follows. A mixture of 1 mL was extruded using a 0.3 mm syringe into 20 mL solution of 0.05 M CaCl 2 and 0.2 M NaCl in distilled water. The microcapsules were allowed to harden for 30 min at 378C. The capsules were then immersed in 20 mL of chitosan solutions (pH 5.0 and 6.0) prepared as described above for 20 min at 378C. The capsules were rinsed with PBS for 1 min and immersed in a 0.05% iota-carrageenan for 5 min. Microcapsules with liquedied core were also prepared using sodium citrate. The obtained iota-carrageenan þ alginate microcapsules obtained above were immersed in a 0.055 M solution of sodium citrate for 1 min [5, 26] . Immersion times 41.5 min disintegrated the liquefied capsules; therefore, 1 min was chosen for comparison with solid capsules. The obtained capsules (solid and liquefied) were rinsed twice with PBS buffer and stored at 48C in the buffer for characterization. The capsules were immersed in Dulbecco's Modified Eagle's Medium (DMEM) to assess the stability of the microcapsules in culture medium and to observe the capsule permeability.
Morphological Characterization of Microcapsules
The size and shape of the microcapsules were examined by stereomicroscopy (Zeiss-Stemi 2000-C KL 1500 LCD, 459315) and with an inverted light microscope (Zeiss, Axiovert 40 CFL, 459306). The capsules were stained in 0.1% (w/v) eosin dye (eosin Y solution, alcoholic with phloxine B 0.1% (w/v)/HT110316, Sigma-Aldrich, Portugal) to observe the membranes.
Evaluation of Mechanical Stability
Both the solid and partially liquefied microcapsules produced were submitted to a short-term stability evaluation assay and 50 capsules of each type were placed in 24 well plates (10 per well) with 800 mL of PBS solution in each well. The culture plate was then agitated at 200 rpm and 258C for different periods of time, namely 1, 3, 6, 24, and 48 h. The percentage of ruptured capsules, as a function of time, was determined by stereomicroscopy.
Assessment of in vitro Cytotoxicity of the Developed Capsules
To evaluate possible toxic effects of leachables from the microcapsules and polyanions used, MTT testing was used. Latex rubber (Dermagip, WRP) was used as a positive control and standard culture plates (Costar 96 well plate) were used as a negative control. Extracts of the capsules and the positive control were obtained by immersion in culture medium for 24 h at 378C and 60 rpm.
Cell Culture
A mouse lung fibroblast cell line (L929), obtained from European Collection of Cell Cultures (ECC, UK), was used for the cytotoxicity assays. The cells were grown as monolayer in 75 cm 2 culture flasks, using DMEM-low glucose (DMEM-Sigma-Aldrich), supplemented with 10% fetal bovine serum (FBS), 1% antibiotic/antimycotic and sodium bicarbonate at 378C in a 5% CO 2 incubator. Cells were harvested before reaching confluence from 75 cm 2 culture flasks using trypsin-EDTA, and a cell suspension was prepared to obtain a cell density of 6.6 Â 10 4 cells/mL. Cell suspension (200 mL/well) was cultured in a 96 well culture plate in DMEM. After the cells were attached to the culture plate, the culture medium was replaced by 150 mL of extracted capsules prepared in complete culture medium and incubated for 24, 48, and 72 h at 378C.
Preparation of the Extracts
The extracts were obtained by immersing 100 microcapsules (of each type) in a sterile tube containing 5 mL of DMEM and placed in a water bath at 378C and 60 rpm for 24 h and the extract filtered using a 0.45 mm syringe filter. As a positive control, 60 squares of 1 cm 2 of latex rubber were immersed in DMEM culture medium following the same procedure described for the tested materials.
MTT Assay
The MTT solution (50 mL of 1 mg MTT/mL DMEM without phenol red) was added to the cell monolayers, previously exposed to extracts obtained from the capsules and incubated at 378C in a 5% CO 2 incubator for 4 h. The MTT solution was removed and replaced by 10 mL of isopropanol to lyse the cells [27] . The solution became purple and the optical density (OD) was measured in a microplate reader (BIO-TEKSynergy HT) at 570 nm, with a background correction of the OD at 650 nm. The results were expressed as percentage of cell viability calculated using the following equation:
where OD sample is the OD obtained in the cells exposed to each extract/ capsule and OD control the OD obtained in the cells incubated with the culture medium only (negative control) [28] .
Cell Encapsulation
Immobilization of the cells was performed using a L929 fibroblasts cell line in sodium alginate/iota-carrageenan solid and liquefied capsules. Microcapsules and cell encapsulation procedures were carried out at room temperature under sterile conditions, using a laminar flow cabinet. All solutions were prepared in distilled water and filtered using a 0.2 mm membrane filter (Schleicher & Schuell Microscience, Germany). The sodium alginate, iota-carrageenan and chitosan solutions were autoclaved prior to use. The fibroblast cells were initially harvested from monolayer using trypsin-EDTA (Invitrogen, Portugal). A suspension containing 5 Â 10 3 cells per mL of the polymeric solution were mixed with the sodium alginate/iota-carrageenan (30/70) solution. The cell-polymeric suspension was extruded into a calcium chloridesodium chloride (CaCl 2 -NaCl) solution, as described above using a syringe pump. The resulting microcapsules/cells were maintained in CaCl 2 -NaCl for 30 min at 378C in a 5% CO 2 incubator. The capsules containing the cells were then immersed in 20 mL of chitosan solution (adjusted to pH 5.0 with b-GP) for 10 min and at 378C in a 5% CO 2 incubator. The capsules were rinsed with PBS for 1 min and immersed in 0.05% iota-carrageenan for 5 min. To obtain the liquefied capsules, the microcapsules with cells were treated with 0.055 M of sodium citrate for 1 min. Finally, microcapsules with cells were washed twice with PBS, transferred to a 6 well culture plate and immersed in culture medium. The encapsulated cells were cultured in a 5% CO 2 incubator for different periods of time, 1, 2, 3, and 7 days. The culture medium was changed every 2 days.
Morphological Characterization in Encapsulated Cells
The morphology of the microcapsules containing the cells as well as the morphology of the cells, were analyzed using inverted light microscopy and a stereomicroscopy, respectively. The viability of the encapsulated cells were assessed using the methylene blue staining.
MTS Assay
Cellular viability of entrapped fibroblast cells was determined using the MTS testing [29, 30] . The microcapsules (30/70) containing cells (three capsules per well) were immersed in a culture medium containing MTS, in a 5:1 ratio, and incubated at 378C. After 3 h of incubation, 100 mL of the solution obtained from each well (containing the encapsulated cells) were transferred to a 96-well plate. The absorbance was read with a microplate reader (BIO-TEK -Synergy HT) at 490 nm. An alginate/iota-carrageenan mixture (30/70) of fibroblasts cells was used as the control.
Staining of Calcein-AM and DAPI Fluorescents
Two fluorescent dyes were used to assess the cellular viability in encapsulated cells. Calcein-AM, a green dye, was used to identify the viable cells and DAPI, a blue dye, was used to identify cell nucleus in live and fixed cells. In this assay, the capsules were placed into an Eppendorf tube containing 1 mL of DMEM and 2 mL of Calcein-AM and incubated for 20 min at 378C in 5% CO 2 . The capsules were then rinsed in DMEM culture medium and PBS solution. The PBS was replaced by 500 mL of glutaraldehyde (2.5%) for 10 min at room temperature to fix the cells. The excess glutaraldehyde was removed and the capsules were rinsed twice in PBS. A new PBS solution (1 mL) and 2 mL of DAPI were added to the capsules and incubated for 20 min at 378C in 5% CO 2 . The capsules were rinsed twice in PBS and observed under a fluorescence microscope (Zeiss 434301) using Alexa Flour 488 and DAPI 49. All the procedures were performed in the dark.
Statistical Analysis
The results obtained in the mechanical stability tests and in the MTT (in vitro cytotoxicity of capsules' leachables) and MTS tests (as cellular viability of encapsulated cells) are presented as means AE standard deviation. The statistical analysis of the results was performed using the Student's t-test, with a significance level of 95% ( p50.05).
RESULTS AND DISCUSSION
Microcapsules were formed as iota-or kappa-carrageenan complexes. Both carrageenans have polyelectrolytic character and form a thermoreversible gel, which is induced by selected monovalent and/ or divalent metal cations [8, 11] . Based on stereomicroscope and inverted light microscope observations, the kappa-and iotacarrageenans formed spherical-shaped microcapsules with 2.0-2.2 mm diameters ( Figure 1) .
In this study, chitosan solutions, with different pHs were used to form different types of capsules by polyelectrolyte complex and ionotropic gelation method, since changes in the pH alters the protonation degree and bonding interactions in chitosan [31] .
Previous studies have demonstrated that chitosan can be neutralized to physiological pH (7.2) using b-GP, without promoting the precipitation [31, 32] . The capsules formed at pH 5.0, exhibited a smoother surface than the capsules formed at pH 6.0. At pH 5.0, the capsules have higher chitosan protonation that can induce a more homogeneous complex. These results are in accordance with alginate/oligochitosan and carrageenan/oligochitosan systems developed in other studies, where a more compact polyelectrolyte complex with higher crosslinking density was formed [8, 17, 33] .
The thickness and strength of the capsule wall were controlled by varying the Mw of the constituent polymers. The lower Mw forms diffuse through the capsule membrane more rapidly, thus produce thicker walls before being hampered by the diffusion distance. The lower Mw chitosan capsule walls are both thicker and less elastic than those made with higher Mw forms [34] . As a result, the diluted chitosan solution (0.15%) used in the capsules developed produced a membrane with less elasticity but with fewer incidences of physical defects. Moreover, the low Mw chitosan increases its capacity to penetrate and interact with the core polymer [2] .
In general, kappa-carrageenan generated thicker gels in the core as compared to iota-carrageenan (Figure 1 ), which might compromise the exchange of gases and nutrients, harming the viability of the encapsulated cells. Therefore, iota-carrageenan was selected for further studies, concerning the development of microcapsules based on the combination of this polymer with alginate. Previous studies [17] have demonstrated that iota-carrageenan and alginate are similar because both polymers have one anionic group per glucosic unit, producing a more compact and resistant capsule in comparison with kappa-carrageenan which has a lower degree of substitution (one anionic group per two glucosic unit).
The capsules alginate/iota-carrageenan were produced by extruding from a mixture of the two polyanions into a gelling agent (CaCl 2 ) and antigelling agent (NaCl) [35] . According to optical microscope observations, the capsules performed exhibited spherical shape, thin, and smooth surface and revealed good stability in PBS and in culture medium (Figure 1) . The diameter of the solid capsules (non-liquefied) was $2.0 mm, while the average diameters of the liquefied capsules were 2.3 mm. The increase in diameter in liquefied capsules is due to the enhanced swelling of the capsules [18] . The citrate, a sequestering agent, generates a strong bond between calcium ions and non-gelling sodium or potassium ions. The decrease of the Ca 2þ bound between the alginate chains increases the swelling pressure inside the capsule, modifying the original diameter [1, 16] .
The capsules obtained with different iota-carrageenan and alginate ratios and different pHs showed similar size, shape and stability in PBS and culture medium (Figure 2) . However, the capsules obtained at pH 5.0 exhibited a smoother membrane and better handling properties in comparison with capsules obtained at pH 6.0. In previous studies, the pH of a solution was used to modulate the polyelectrolyte membranes. For instance, the cationic polymer chitosan is soluble at low pH, but its solubility decreases as alkaline pH is approached. Moreover, the micropores of chitosan membrane capsule assume minimum dimensions at low pH, but at about pH 6.0 and higher, repulsive forces produce the pores to open up and the membrane permeation to rise. Previous studies showed that NaCl is one of the factors that determines membrane permeability as well as surface topology [35] . The sodium ions control the initial stages of complex formation. The negative charges of the reacting polymers suppress the reaction of calcium ions with the polyanion matrix. Therefore, by increasing the ratio of Na þ to Ca 2þ for a given polyanion mixture, it is possible to obtain a wrinkle-free surface [2] .
The mechanical stability of microcapsules is a major concern in the design of cell immobilization for therapeutic devices where good mechanical stability is needed to prolong in vivo function [36] . The short-term stability had similar numbers of ruptured capsules for all the systems (Figure 3) . The capsules produced using a mixture 50/50 sodium alginate/ iota-carrageenan of the polymers exhibited lower stability in the mechanical study (AE10% more of ruptured capsules) compared to capsules formed using 30/70 SA-IC polymers. The increase in the iota-carrageenan content of this formulation produced higher amounts of ionic sulfate groups that repel each other and contribute for the molecules being highly extended. The gradual substitution of alginate (a rigid polymer) with carrageenan (a flexible polymer) provided the flexibility required to adapt to the varying stress of tidal and wave motion caused by the agitation [37, 38] .
In the first 6 h, liquefied and solid (non-liquefied) 50/50 SA-IC capsules, presented similar behavior (Figure 4) . However, the 30/70 SA-IC composition had greater mechanical stability for that time period. This suggests that the decreasing stability is caused by the swelling effect related to the treatment with sodium citrate, which affects the capsules with higher concentration of alginate. After 24 h, rupturing of both 30/70 and 50/50 non-liquefied capsules increased, which could be related to the mass transfer of PBS through the capsule membrane. It is known that mass transfer is greater in liquefied capsules and that equilibrium is reached faster than in the non-liquefied. However, before reaching equilibrium, the mass transfer in the non-liquefied capsule may occur predominantly from the solution to the interior of the capsules, leading to their bursting.
Solid capsules (non-liquefied) were reported to be mechanically more resistant than liquefied capsules, which was attributed to the swelling effect induced by the citrate solution during production of the liquefied capsules [16, 18, 39] . In our study, statistically significant differences were not found in the stability of solid and liquefied alginate/iota-carrageenan capsules, probably due to the structure and distribution of the mixed polymers used. Accordingly, the 30/70 sodium alginate/iota-carrageenan (solid and liquefied) capsules were selected for the posterior cell encapsulation assays. The metabolic activity and viability of the fibroblast cultured with leachables extracted from 30/70 and 50/50 sodium alginate/iota-carrageenan solid capsules were assessed using MTT test for three different periods of culture (24, 48 , and 72 h). Optical observations (before adding the MTT solution) revealed a good cell growth and attachment. No changes in cell morphology were detected in comparison with negative control (Figure 5 ), demonstrating the non-cytotoxicity of these capsule formulations. The cell viability of all the capsules was similar for all the culturing periods. However, the cell viability, determined using MTT in cells exposed to extracts of 50/50 sodium alginate/iota-carrageenan capsules, was lower compared to the cells exposed to the extract obtained from the 30/70 sodium alginate/iota-carrageenan capsules ( Figure 6 ). The capsules with higher alginate could be producing leachable material that induce a reaction with the cells exposed to their extracts.
Viability and Proliferation of Encapsulated Cells
Based on the mechanical stability evaluation, it was decided to use the 30/70 sodium alginate/iota-carrageenan solid and liquefied capsules aggregation. This is relevant since previous studies showed that cell aggregates could produce necrotic spaces within the capsules as a consequence of poor mass transfer [18, 40] .
In previous studies, cells enclosed in liquefied beads improved growth profile in comparison to the cells entrapped in solid capsules [18, 26] . However, in this study, the solid and liquefied capsules, using sodium alginate/iota-carrageenan as polyanions, showed a similar behavior. These results can be explained by the mixture and proportion of polymers, for example, iota-carrageenan is present in higher proportion (70%) than sodium alginate (30%). The iota-carrageenan confers an elastic structure to the core of the capsule, providing more flexibility as opposed to the sodium alginate that has a rigid structure [37, 41] .
Cellular viability and proliferation were also determined by MTS tests after culturing fibroblast cells 72 h in 30/70 SA-IC (solid and liquefied) capsules. A sodium alginate/iota-carrageenan (30/70) mixture with cells was also evaluated as a control. The cell viability decreased in the encapsulated cells but increased in the cell/solution mixture (Figure 8) . However, the cell viability of both types of capsules did not show significant differences after 72 h, indicating that the citrate treatment may not be relevant to improve the permeability of the capsules and hence for cell viability, using this polymeric formulation.
The cultured cell/solution did show increased cell viability with a homogeneous growth, further demonstrating the non-cytotoxicity of this mixture, confirming the MTT assays. These results also indicate that the decrease in cell viability over time in the capsules may be due to a decrease in permeability resulting from the membrane formation during the capsule preparation. In fact, the cell growth is better in cells/solution of SA-IC than in the capsules because the molecules and gases did not have to cross the membrane present in the capsule to reach the cells.
Calcein-AM fluorescent staining was used to confirm the viability of encapsulated cells (capsules 30/70, solid and liquefied); green and blue staining was evident after 7 days of cell culture ( Figure 9 ). These results confirmed the permeability and non-toxicity of the capsule developed with sodium alginate and iota-carrageenan polymers. No differences in cell viability between encapsulated fibroblast in the solid and liquefied capsules were observed. The cells exhibited similar distribution and fluorescence patterns in both types of capsules. However, after 7 days, the cells in both capsules showed low fluorescence, possibly because of decreased cell viability. The results obtained indicate that Calcein-AM and DAPI were able to penetrate the alginate-carrageenan capsules containing living fibroblast cells in suspension with intact membrane, reveal cell viability within the construct. The capsules had differences in the cell viability and proliferation, as confirmed in the MTS test. Furthermore, no cell aggregates were detected by fluorescence staining (Figure 9 ).
CONCLUSIONS
Microcapsules developed via ionotropic gelation of sodium alginate and iota-carrageenan solutions provided stable capsules when chitosan was the main component of the capsule membrane. The mechanical properties of these capsules were influenced by the alginate/carrageenan ratio. The short-term stability evaluations indicate that the capsules with higher iota-carrageenan content are more stable and that the stability is not affected by the citrate treatment. The cells encapsulated in both solid and liquefied 30/70 SA-IC capsules maintained their viability and did not aggregate. Citrate treatment did not improve the permeability of iotacarrageenan/sodium alginate capsules made with high carrageenan (70%) content. This new polymeric mixture of alginate with iota-carrageenan produced a promising system for cell encapsulation that may have several applications in tissue engineering and other cell therapies.
